Assessment of ionising radiation exposure of the staff and roommates from the cancer palliatively treated by Quadramet<sup>TM</sup>  with Sm-153

Aldona Kowalska; Anna Żórawska

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

8/2002
vol. 6

Send email

Copy url:

abstract:

Assessment of ionising radiation exposure of the staff and roommates from the cancer palliatively treated by Quadramet^TM with Sm-153

Aldona Kowalska

,

Anna Żórawska

Współcz Onkol (2002), vol. 6, 8, 522-525

Online publish date: 2003/03/26

View full text Get citation

Quadramet^TM is a radiopharmaceutic including Sm-153 applied in the osseous pain caused by cancer metastasis. Quadramet is effective and in some cases the only agent used in palliative treatment in a view of its specific property as:
- a short physical half life,
- possibility of administer of high doses,
- adequate type and radiation energy
- relatively low toxicity.
High emission of radiant energy of Quadramet can inspire fears considering the size of exposure of staff and roommates. In order to assess this value the dosimetry measurements were carried out, which gave the real picture of the exposure. In this paper the results of the measurements and conclusions are presented.

keywords:

Assessment of ionising radiation exposure of the staff and roommates from the cancer palliatively treated by QuadrametTM with Sm-153

Aldona Kowalska , Anna Żórawska

Quadramet, radiation protection

Assessment of ionising radiation exposure of the staff and roommates from the cancer palliatively treated by Quadramet^TM with Sm-153

Aldona Kowalska

,

Anna Żórawska